Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL-43546 in Shortened Tear Film Break Up Time
NCT00760045Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Aug 2008
- Primary completion
- Oct 2008
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxypropyl-guar in dry eye disease (DED), sponsored by Alcon Inc.. Started Aug 2008; status: completed.
02
Drugs
hydroxypropyl-guar
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT00760045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00760045.